Bhoom Suktitipat

Bhoom Suktitipat

Auto-generated profile, based on publicly available information

Bhoom Suktitipat

Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SLSymen Ligthart
Symen Ligthart
AVAhmad Vaez
Ahmad Vaez
UVUrmo Võsa
Urmo Võsa
MSMaria G. Stathopoulou
Maria G. Stathopoulou
PVPaul S. de Vries
Paul S. de Vries
EBEmelia J. Benjamin
Emelia J. Benjamin

1 January 2011 in BMC Genetics
Verified
Journal Article
Open access
PDF file
RMRasika A Mathias
Rasika A Mathias
SSSusan Sergeant
Susan Sergeant
IRIngo Ruczinski
Ingo Ruczinski
DTDara G Torgerson
Dara G Torgerson
CHChristina E Hugenschmidt
Christina E Hugenschmidt
FCFloyd (Ski) H. Chilton
Floyd (Ski) H. Chilton
Arachidonic acid (AA) is a long-chain omega-6 polyunsaturated fatty acid (PUFA) synthesized from the precursor dihomo-gamma-linolenic acid (DGLA) that plays a vital role in immunity and inflammation. Variants in the Fatty Acid Desaturase (FADS) family of genes on chromosome 11q have been shown to play a role in PUFA metabolism in populations of European and Asian ancestry; no work has been done in populations of African ancestry to date.

23 September 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PTPariyada Tanjak
Pariyada Tanjak
BSBhoom Suktitipat
Bhoom Suktitipat
NVNutchavadee Vorasan
Nutchavadee Vorasan
PJPanudeth Juengwiwattanakitti
Panudeth Juengwiwattanakitti
BTBenjarat Thiengtrong
Benjarat Thiengtrong
VCVitoon Chinswangwatanakul
Vitoon Chinswangwatanakul
Background: The situation of patients developing multiple primary cancers is becoming more frequent and graver. This study investigated the risks of developing second primary cancers that are related to first primary cancers, and the interval times of synchronous and metachronous multiple primary cancers. Patients and methods: Retrospective data were retrieved from 109,054 patients aged ≥18 who were diagnosed with a first solid cancer and registered at Siriraj Cancer Center between 1991 and 2015. A two-month period between first- and second- primary cancers was used to differentiate metachronous and synchronous multiple primary cancers. The combinations of subsequent cancers and relative risks (RRs) of having multiple primary cancers versus having single primary cancer for the top-ten first and second primary cancers were examined. The RR was adjusted for age of the first primary cancer. A survival analysis of the time to second-primary-cancer development was performed. Results: Multiple primary cancers were found in 1785 (1.63%) patients. Most (70.87%) second primary cancers occurred after 2 months of first breast, skin, colorectal, lung, head and neck, liver, male genital cancer–prostate, thyroid, and female genital cancer–non-uterine cancers, resulting in those cancers being classified as metachronous multiple primary cancer. After adjustment for age at first diagnosis, head and neck cancers had the highest metachronous association with second esophageal cancers (RR, 25.06; 95% CI, 13.41–50.77). Prostate cancer and second colorectal cancer also demonstrated a high metachronous association (RR, 2.00; 95% CI, 1.25–3.05). A strong synchronous association was found between uterine and ovarian cancers (RR, 27.77; 95% CI, 17.97–43.63). The median time from the first uterine cancer to second-cancer development was 55 days. Conclusions: The top-ten most frequent multiple primary cancers were the following: breast; liver; head and neck; colorectal; male genital cancer–prostate; skin; female genital cancer–uterine; thyroid; lung; and female genital cancer–non-uterine. Second primary cancers showed specific associations that depended on the first primary cancer. Physicians should be cognizant of the most common combinations and the interval times of metachronous and synchronous multiple primary cancers.

22 September 2011 in Blood
Verified
Journal Article
Closed access
PDF file
NFNauder Faraday
Nauder Faraday
LYLisa R. Yanek
Lisa R. Yanek
XYXiao Ping Yang
Xiao Ping Yang
RMRasika Mathias
Rasika Mathias
JHJ. Enrique Herrera-Galeano
J. Enrique Herrera-Galeano
LBLewis C. Becker
Lewis C. Becker
Genetic variation is thought to contribute to variability in platelet function; however, the specific variants and mechanisms that contribute to altered platelet function are poorly defined. With the use of a combination of fine mapping and sequencing of the platelet endothelial aggregation receptor 1 (PEAR1) gene we identified a common variant (rs12041331) in intron 1 that accounts for ≤ 15% of total phenotypic variation in platelet function. Association findings were robust in 1241 persons of European ancestry (P = 2.22 × 10−8) and were replicated down to the variant and nucleotide level in 835 persons of African ancestry (P = 2.31 × 10−27) and in an independent sample of 2755 persons of European descent (P = 1.64 × 10−5). Sequencing confirmed that variation at rs12041331 accounted most strongly (P = 2.07 × 10−6) for the relation between the PEAR1 gene and platelet function phenotype. A dose-response relation between the number of G alleles at rs12041331 and expression of PEAR1 protein in human platelets was confirmed by Western blotting and ELISA. Similarly, the G allele was associated with greater protein expression in a luciferase reporter assay. These experiments identify the precise genetic variant in PEAR1 associated with altered platelet function and provide a plausible biologic mechanism to explain the association between variation in the PEAR1 gene and platelet function phenotype.

6 October 2011 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
ANAmidou N'DIaye
Amidou N'DIaye
GCGary K. Chen
Gary K. Chen
CPCameron D. Palmer
Cameron D. Palmer
BGBing Ge
Bing Ge
BTBamidele Tayo
Bamidele Tayo
CHChristopher A. Haiman
Christopher A. Haiman
Adult height is a classic polygenic trait of high heritability (h2 ∼0.8). More than 180 single nucleotide polymorphisms (SNPs), identified mostly in populations of European descent, are associated with height. These variants convey modest effects and explain ∼10% of the variance in height. Discovery efforts in other populations, while limited, have revealed loci for height not previously implicated in individuals of European ancestry. Here, we performed a meta-analysis of genome-wide association (GWA) results for adult height in 20,427 individuals of African ancestry with replication in up to 16,436 African Americans. We found two novel height loci (Xp22-rs12393627, P = 3.4×10−12 and 2p14-rs4315565, P = 1.2×10−8). As a group, height associations discovered in European-ancestry samples replicate in individuals of African ancestry (P = 1.7×10−4 for overall replication). Fine-mapping of the European height loci in African-ancestry individuals showed an enrichment of SNPs that are associated with expression of nearby genes when compared to the index European height SNPs (P180 single nucleotide polymorphisms (SNPs) associated with height. In the current study, we continued to use height as a model polygenic trait and explored the genetic influence in populations of African ancestry through a meta-analysis of GWA height results from 20,809 individuals of African descent. We identified two novel height loci not previously found in Europeans. We also replicated the European height signals, suggesting that many of the genetic variants that are associated with height are shared between individuals of European and African descent. Finally, in fine-mapping the European height loci in African-ancestry individuals, we found SNPs more likely to be associated with the expression of nearby genes than the SNPs originally found in Europeans. Thus, our results support the utility of performing genetic studies in non-European populations to gain insights into complex human diseases and traits.

11 May 2009 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
AKAlison P Klein
Alison P Klein
BSBhoom Suktitipat
Bhoom Suktitipat
PDPriya Duggal
Priya Duggal
KLKristine E. Lee
Kristine E. Lee
RKRonald Klein
Ronald Klein
BKBarbara E. K. Klein
Barbara E. K. Klein
Quantitative refraction is influenced by the underlying morphology of the eye: axial length, corneal curvature, and anterior chamber depth. Refractive errors are common in the Beaver Dam Eye Study cohort, with 26.2% being myopic (≥−0.75 diopters [D] negative) and 49.0% being hyperopic (≥+0.75 D positive). Environmental factors have been reported to be associated with refraction, the most notable being nearwork or educational attainment, a surrogate measure for nearwork.1-5We have reported that longer axial length was associated with an increase in years of education and height within this cohort. Greater corneal curvature and deeper anterior chambers were also associated with increase in height and educational attainment.6